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Abstract
Background: EBUS-TBNA is an established technique for diagnostically sampling intrathoracic masses and lymph
nodes. While the procedure is commonly conducted under general anesthesia (GA), little is known regarding the association between anesthetic management and perioperative respiratory complications. Here, we aim to evaluate this
association among patients presenting for EBUS-TBNA.
Methods: 586 patients receiving GA for EBUS-TBNA between 2012 and 2018 were retrospectively evaluated. The
primary endpoint was the occurrence of perioperative respiratory complications and the secondary endpoint was procedure end to OR exit time (minutes). Respiratory complications were deﬁned as episodes of severe (SpO2 <85%) or
prolonged (SpO2<90% for >5 min) hypoxemia, bronchospasm, and postoperative ventilation that could not be directly
attributed to procedural invasiveness.
Results: Among all patients, 79 (13.5%) had respiratory complications. Four patient characteristics were associated with
respiratory complications: home oxygen use (OR 2.39; 95% CI 1.26e4.45; P ¼ 0.007), pre-existing respiratory disease (OR
2.01; CI 1.21e3.29; P ¼ 0.005), ASA class (P ¼ 0.03), and albuterol administration intra-operatively (OR 2.22; CI 1.23e3.92;
P ¼ 0.007). No anesthetic factors were found to be statistically signiﬁcant. Procedures with respiratory complications had
a longer duration (mean time 88.7 min vs. 111.8 min; P ¼ 0.00009), prolonged time to extubation (mean time 11.9 min vs.
14.2 min; P ¼ 0.039), and stayed in the room longer after extubation (mean time 18.4 min vs. 23.1 min; P ¼ 0.0016). When
comparing types of GA, there were no signiﬁcant differences between volatile anesthetics versus TIVA (12.7% vs. 14.6%,
P ¼ 0.54).
Conclusions: Pre-existing patient characteristics, as opposed to anesthetic factors, are associated with respiratory
complications during EBUS-TBNA.
Keywords: General anesthesia, EBUS-TBNA, Respiratory complications, Interventional pulmonology

1. Introduction

E

ndobronchial
Ultrasound-guided
Transbronchial Needle Aspiration (EBUS-TBNA) is a
minimally invasive and highly accurate technique
for sampling intrathoracic masses and lymph nodes
to diagnose non-malignant and malignant pulmonary diseases.1e4 Comparative studies have shown
that EBUS-TBNA is superior to conventional TBNA
as well as mediastinoscopy for lung cancer staging,

and as a consequence EBUS-TBNA has become
widely adopted.5e7 Most EBUS-TBNA studies
deﬁne primary outcomes of diagnostic accuracy,
yield, and efﬁcacy.8e10 However, there have been
few signiﬁcant studies focused on procedural
safety with the aim of quantifying the incidence of
and risk factors for perioperative complications. In
these studies, the complications are addressed
broadly in range and scope, with no focused
assessment of complications that cannot be
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attributed to the invasiveness of the surgical procedure itself.7,11e14
Patients undergoing EBUS-TBNA often receive
anesthesia with varying degrees of success. It has
been reported previously in the literature that
minimal, moderate, and deep sedation are safe and
efﬁcacious.15e19 In both retrospective and prospective studies of sedation techniques, continuous
propofol infusion, midazolam, meperidine, ketamine-midazolam, ketamine-propofol, propofolmidazolam, and midazolam-fentanyl have all shown
similar effectiveness.15,20e23 However, CasesViedma et al. demonstrated fewer respiratory and
non-respiratory complications when combined
midazolam-propofol and combined midazolamfentanyl were used for patient sedation.15 Additionally, bispectral index monitoring has been
shown to decrease the number of adverse events,
including hypoxia and hypotension, when administering sedation for EBUS-TBNA.24
Compared to sedation, there are few studies that
have demonstrated the safety and efﬁcacy of various
general anesthetic techniques for EBUS-TBNA.
Zamparelli et al. has demonstrated that general
anesthesia (GA) can be safely administered utilizing
an endotracheal tube (ETT) or an LMA for EBUSTBNA. Further, it has been shown that minor
complications of a procedural, respiratory, or cardiac nature are less likely to occur with GA
compared to sedation.25,26 However, the 2013
AQuIRE registry study notably determined both
deep sedation and GA are risk factors for escalation
of care post-procedure and that evidence is lacking
regarding any strong recommendation favoring one
method of GA over another.12 Additionally,
inherent mechanisms underlying GA can contribute
to respiratory complications via decreased functional residual capacity, impaired ventilatory drive
leading to respiratory depression, and increased
ventilation-perfusion mismatch.27,28
Due to the lack of recommendations regarding
perioperative management of patients presenting
for EBUS-TBNA, we retrospectively analyzed the
perioperative course of 586 patients undergoing
EBUS-TBNA with GA at our institution over a sixyear period. Speciﬁcally, we assessed their perioperative courses for the occurrence of respiratory
complications that could not be directly attributed to
the invasiveness of the procedure. The primary
objective was to quantify the incidence of, and risk
factors for, respiratory complications with a focus on
anesthetic management and how selection of agents
may inﬂuence procedural outcomes. The secondary
outcome of this study was to assess whether anesthetic management inﬂuenced the duration of time

Abbreviation list
ASA
American Society of Anesthesiologists
BAL
Bronchoalveolar Lavage
COPD
Chronic obstructive pulmonary disease
EBUS-TBNA
Endobronchial ultrasound-guided
transbronchial needle aspiration
ETT
Endotracheal tube
FRC
Functional residual capacity
GA
General Anesthesia
LMA
Laryngeal Mask Airway
OR
Operating Room
OSA
Obstructive Sleep Apnea
SpO2
Oxygen saturation
TB
Tuberculosis
TIVA
Total intravenous anesthesia

the patient needed to be monitored post-procedurally prior to operating room (OR) exit.

2. Materials and methods
We performed a retrospective analysis of 586 patients undergoing bronchoscopy with lymph node
sampling by EBUS-TBNA under GA from 2012 to
2018 at a single university hospital center. Approval
was obtained from the university's Institutional Review Board (Protocol HP-00076323), with waiver of
consent obtained in accordance with institutional
guidelines. All patients who underwent EBUS-TBNA
under GA during this time interval were included in
this study. All procedures were performed using
Olympus™ EBUS bronchoscopes (BF-UC180F) and
Olympus™ ViziShot EBUS-TBNA needles (21G and
22G). Patient selection for GA was based on patient
co-morbidities, anticipated length of procedure, patient preference, and resource allocation. The needle
gauge used during the procedure was selected at the
discretion of the bronchoscopist. The anesthetic
regimen used during the procedure was selected at
the discretion of the anesthesiologist.
Information extracted from patient charts included
demographics, clinical characteristics, sedation and
general anesthetic information, procedural information, pathology results, complications, and outcomes
of complications. The presence of pre-existing respiratory disease among patients was deﬁned as
any chronic pulmonary condition diagnosed prior to
the patient's EBUS-TBNA procedure. Conditions
included, but were not limited to, the following:
asthma, chronic obstructive pulmonary disease,
pulmonary tuberculosis, pulmonary sarcoidosis,
obstructive sleep apnea, and emphysema.
The primary outcome was respiratory complication, deﬁned as any of the following events: severe
(any desaturation to SpO2 <85%) or prolonged

(SpO2<90% for >5 min) hypoxemia, bronchospasm,
or postoperative ventilation. The timing and degree
of desaturation for all hypoxemia events was
tracked through MetaVision (iMDsoft, Needham,
MA), an electronic anesthesia medical recording
software. MetaVision automates the intraoperative
recording of the American Society of Anesthesiologists standard monitors in real-time at 1-min intervals including heart rate, blood pressure, oxygen
saturation (SpO2) and temperature. Bronchospasm
was assessed by physical exam, auscultation, and
peak airway pressures (if available). If a case was
described in the procedural notes as having had a
complication (respiratory or otherwise) due to the
procedure itself or the actions of the proceduralist,
then it was deemed a procedural complication and
excluded from this study. Any respiratory complication documented by anesthesia providers or
tracking software, in the setting of complication-free
procedural records, was counted as a respiratory
complication for the purposes of this study. The
secondary outcome was time from procedure end to
OR exit. All outcomes were deﬁned prior to preforming any data analysis.
2.1. Statistical analysis
In the bivariate analysis, categorical data were
compared using the Fisher's exact test and Pearson's
Chi-squared test. Non-categorical data were
compared using the ManneWhitney U test. Multivariable linear and logistic regression was used to
examine the association of outcomes with patient,
clinical, and anesthetic characteristics. For the
multivariable logistic regression analysis, we
decided a priori that variables with P values < 0.05 in
the bivariate analysis would be the candidate variables in the multivariable logistic regression model.
These selected variables included home oxygen use,
pre-existing respiratory disease, albuterol use intraoperatively, ASA class, total procedure duration,
procedure end to extubation time, and procedure
end to OR exit time post-extubation. For the multivariable linear regression model, we decided a posteriori to select variables known to extend or
inﬂuence operative times under other circumstances.
These variables included weight (kg), ketamine,
fentanyl dosage, age, total intravenous anesthesia
(TIVA), ASA class, total procedure duration, home
oxygen use, succinylcholine use, rocuronium use,
and rocuronium redosing. P-values <0.05 were
considered statistically signiﬁcant. All tests were two
sided. Statistical analyses were performed utilizing
GraphPad Prism 8, Python 3.4, and R 3.5.2.
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3. Results
A total of 586 patients were enrolled in this
retrospective study from one institution. Baseline
patient characteristics and GA factors are summarized in Table 1.
3.1. Respiratory complications
Among the 586 patients, 79 (13.5%) had respiratory complications of EBUS-TBNA that could not be
directly attributed to the invasiveness of the procedure (Table 2). These respiratory complications
include severe or prolonged hypoxemia, or bronchospasm. Three of the 79 patients (3.8%) also
required post-operative ventilation as well as subsequent unplanned hospital admission. Notably,
62% of patients who experienced a respiratory
complication also had at least one pre-existing
chronic respiratory disease, while 21.5% had home
oxygen requirements.
Table 3 shows the bivariate analysis for categorical
patient, clinical, and anesthetic characteristics evaluated in this study. Notably, home oxygen use was
associated with an increased risk of respiratory
complications (24.6%), compared with 12% among
those who did not (OR 2.39; 95% CI 1.26e4.45;
P ¼ 0.007). Additionally, pre-existing respiratory
disease (OR 2.01; CI 1.21e3.29; P ¼ 0.005), ASA class
(P ¼ 0.03), and albuterol administration intra-operatively (OR 2.22; CI 1.23e3.92; P ¼ 0.007) were also
associated with increased respiratory complications
(Table 3). However, diagnosis with multiple chronic
respiratory diseases, as opposed to one, was not
associated with a statistically signiﬁcant increased
risk of perioperative respiratory complications
(12.9% vs. 16.9%; P ¼ 0.38).
Procedures with respiratory complications had a
longer duration (mean time 88.7 min vs. 111.8 min;
P ¼ 0.00009) and a prolonged time to extubation
after the procedure (mean time 11.9 min vs.
14.2 min; P ¼ 0.039). Furthermore, these patients
stayed in the OR longer after the conclusion of the
procedure (mean time 18.4 min vs. 23.1 min;
P ¼ 0.0016) (Table 4). In multivariable logistic
regression analysis, only total procedure duration
(OR 0.016; CI 1.008e1.024, P¼<0.0001) and intraoperative albuterol use (OR 1.83; CI 1.007e3.226;
P ¼ 0.041) were independent variables predictive of
respiratory complications (Table 5). Home oxygen
use, pre-existing respiratory disease, ASA class,
procedure end to extubation time, and procedure
end to OR exit time were not statistically signiﬁcant
predictors.
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Table 1. Patient demographics, clinical and anesthetic characteristics.

Table 1. (continued )

Variable

Value

Variable

Value

Total Number of Patients
Age, years
Mean ± SD
Median
>65
Male
Female
Smoking Status
Current
Former
Never
Pack Years, Mean ± SD
Weight, kg
Mean ± SD
Median
Home O2 Use
Pre-existing Respiratory Disease
¼1
>1
Number of TBNA passes
Mean ± SD
Median
Total Procedure Duration (minutes)
Mean ± SD
Median
Procedure End to Extubation (minutes)
Mean ± SD
Median
Procedure End to OR exit (minutes)
Mean ± SD
Median
Prior EBUS/Bronchoscopy
LMA
Sevoﬂurane
Isoﬂurane
Desﬂurane
Nitrous Oxide
Inhaled maintenance of anesthesia
TIVA
Rocuronium
with neostigmine
with sugammadex
with no reversal
Rocuronium re-dosed
Succinylcholine
Vecuronium
Neostigmine
Sugammadex
Etomidate Induction
Propofol Induction
Propofol Infusion
Fentanyl
Remifentanil
Glycopyrrolate
Dexamethasone
Albuterol
Ketamine

586

ASA physical status
1
2
3
4

3 (0.5%)
115 (19.6%)
411 (70.2%)
57 (9.7%)

63.7 ± 12.8
65
296 (50.5%)
336 (57.3%)
250 (42.7%)
157 (26.8%)
281 (48.0%)
148 (25.2%)
39.9 ± 28.7
79.7 ± 20.9
77
69 (11.8%)
276 (47.1%)
83 (14.2%)
4.1 ± 2
4
91.9 ± 41.3
86
12.3 ± 8.6
11
19 ± 11.6
17
125 (21.3%)
35 (6.0%)
305 (52.0%)
18 (3.1%)
8 (1.4%)
10 (1.7%)
347 (59.2%)
239 (40.8%)
489 (83.4%)
152 (31.1%)
282 (57.7%)
55 (11.2%)
176 (30.0%)
122 (20.8%)
16 (2.7%)
286 (48.8%)
162 (27.6%)
14 (2.4%)
571 (97.4%)
377 (64.3%)
519 (88.6%)
241 (41.1%)
299 (51.0%)
134 (22.9%)
92 (15.7%)
16 (2.7%)
(continued on next column)

Data are presented as Total Number of Patients (%) unless
otherwise indicated. ASA ¼ American Society of Anesthesiologists.
TBNA
¼
transbronchial
needle
aspiration.
EBUS ¼ endobronchial ultrasound. LMA ¼ laryngeal mask
airway. TIVA ¼ total intravenous anesthesia.

We also assessed the association of neuromuscular blockade and reversal agent choice with respiratory complications. Rocuronium use occurred in
83.4% of all patients with 31.1% of those patients
receiving neostigmine, 57.7% receiving sugammadex, and 11.2% receiving no reversal (Table 1).
Respiratory complications were not associated with
the use of neostigmine or sugammadex for reversal
(16.4% and 12.1%, P ¼ 0.24) (Table 3). When we
assessed the GA regimen overall, we found that
there were no signiﬁcant associations between respiratory complications and the use of inhalation
maintenance versus total intravenous anesthesia
(TIVA) (12.7% vs. 14.6%, P ¼ 0.54). With regards to
opiate use intraoperatively, respiratory complication
rates were more common with remifentanil use as
opposed to fentanyl but not to a statistically significant degree (21.6% vs. 11.7%; P ¼ 0.35).
3.2. Time to operating room exit
Table 6 presents the independent variables that
are predictive of prolonged post-extubation time to
OR exit. In a multivariable linear regression analysis, weight (Estimate 0.052; P ¼ 0.029), fentanyl
dosage (Estimate 0.013; P ¼ 0.028), and ketamine
dosage (Estimate 9.09; P ¼ 0.0018) were positively
associated with longer OR exit times. Age, TIVA,
ASA class, succinylcholine, rocuronium, rocuronium redosing, case length, and home oxygen use
were not statistically signiﬁcant predictors.

4. Discussion
EBUS-TBNA is a minimally invasive and highly
accurate technique for sampling intrathoracic
masses and lymph nodes for diagnostic purposes.
While this procedure is considered safe, there are
very few studies that investigate the effects of GA on

Table 2. Respiratory complications following EBUS-TBNA
Respiratory Complications

Number of Patients

Total number of patients with respiratory complications
 Severe Hypoxemia (<85%)
 Prolonged Hypoxemia (<90% for >5 min)
 Severe and Prolonged Hypoxemia
 Bronchospasm
 Bronchospasm with severe and prolonged hypoxemia
 Bronchospasm requiring post-operative intubation
 Severe hypoxemia requiring post-operative intubation

79
55 (69.6%)
6 (7.6%)
8 (10.1%)
5 (6.3%)
2 (2.5%)
2 (2.5%)
1 (1.4%)

Data are presented as Total Number of Patients (%) unless otherwise indicated.
Table 3. Categorical patient, clinical, and anesthetic characteristics by occurrence of respiratory complications.
Variable
Age
<65
>65
Sex
Female
Male
Smoking Status
Current
Former
Never
Home O2 Use
Pre-Existing Respiratory Disease
Multiple (>1) Respiratory Diseases
Prior EBUS/Bronchoscopy
ASA Score
1
2
3
4
Sevoﬂurane
Isoﬂurane
Desﬂurane
Nitrous Oxide
TIVA vs. Inhalation
Inhalation
TIVA
Rocuronium
Rocuronium Redosed
Succinylcholine
Vecuronium
Neostigmine
Sugammadex
Neostigmine vs. Sugammadex
Neostigmine
Sugammadex
Propofol Bolus
Propofol Infusion
Etomidate
Fentanyl
Remifentanil
Ketamine
Fentanyl vs. Remifentanil
Fentanyl
Remifentanil
Both
None
Glycopyrrolate
Dexamethasone
Albuterol

No Complication
n ¼ 507

Yes Complication
n ¼ 79

254 (87.6%)
253 (85.5%)

36 (12.4%)
43 (14.5%)

214 (85.6%)
293 (87.2%)

36 (14.4%)
43 (12.8%)

133 (84.7%)
247 (87.9%)
127 (85.8%)
52 (75.4%)
227 (82.2%)
69 (83.1%)
103 (82.4%)

24
34
21
17
49
14
22

(15.3%)
(12.1%)
(14.2%)
(24.6%)
(17.8%)
(16.9%)
(17.6%)

3 (100%)
108 (93.9%)
345 (83.9%)
51 (89.5%)
269 (88.2%)
16 (88.9%)
5 (62.5%)
8 (80%)

0 (0%)
7 (6.1%)
66 (16.1%)
6 (10.5%)
36 (11.8%)
2 (11.1%)
3 (37.5%)
2 (20%)

303 (87.3%)
204 (85.4%)
422 (86.3%)
147 (83.5%)
101 (82.8%)
13 (81.3%)
252 (88.1%)
135 (83.3%)

44 (12.7%)
35 (14.6%)
67 (13.7%)
29 (16.5%)
21 (17.2%)
3 (18.7%)
34 (11.9%)
27 (16.7%)

127 (83.6%)
248 (87.9%)
494 (86.5%)
323 (85.7%)
13 (92.9%)
453 (87.3%)
204 (84.6%)
13 (81.3%)

25 (16.4%)
34 (12.1%)
77 (13.5%)
54 (14.3%)
1 (7.1%)
66 (12.7%)
37 (15.4%)
3 (18.7%)

278 (88.3%)
29 (78.4%)
175 (85.8%)
25 (83.3%)
260 (87.2%)
111 (82.8%)
71 (77.2%)

37 (11.7%)
8 (21.6%)
29 (14.2%)
5 (16.7%)
38 (12.8%)
23 (17.2%)
21 (22.8%)

P-valuea

OR (95% CI)b

0.47

1.19 (0.73e1.95)

0.63

0.87 (0.53e1.42)

0.62

—b

0.007
0.005
0.38
0.14
0.03

2.39
2.01
0.73
1.51
—b

(1.26e4.45)
(1.21e3.29)
(0.39e1.37)
(0.88e2.65)

0.23
1.00
0.08
0.63
0.54

0.74
0.79
3.95
1.62
1.18

(0.46e1.22)
(0.13e3.33)
(0.81e16.5)
(0.24e7.59)
(0.72e1.95)

0.87
0.19
0.18
0.46
0.28
0.18
0.24

1.12
1.42
1.45
1.49
0.76
1.43
0.69

(0.58e2.28)
(0.85e2.33)
(0.83e2.57)
(0.36e5.32)
(0.47e1.26)
(0.84e2.37)
(0.39e1.24)

1.00
0.45
0.71
0.13
0.27
0.46
0.35

1.01
1.23
0.49
0.61
1.31
1.49
—b

(0.22e6.39)
(0.74e2.06)
(0.02e3.09)
(0.31e1.19)
(0.81e2.13)
(0.36e5.32)

0.63
0.19
0.007

0.88 (0.55e1.43)
1.46 (0.83e2.52)
2.22 (1.23e3.92)

Categorical data are presented as Total Number of Patients (%) unless otherwise indicated. Complications denotes the occurrence of any
respiratory complication that is not directly attributable to the invasiveness of the procedure. These complications are described in Table 2.
Statistically signiﬁcant results are indicated in bold.
a
Fisher exact test was used to calculate p-values unless the contingency table >2  2, then a Chi-squared test was used to compute p-value.
b
Odds ratio cannot be calculated off of a 3  2 table.
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Table 4. Non-categorical patient, clinical, and anesthetic characteristics.
Variable

Min.

Mean

Age (years)
No Complications
18
63.8
Complications
20
63.2
Weight (kg)
No Complications
32
78.8
Complications
40
84.6
Total Procedure Duration (minutes)
No Complications
20
88.7
Complications
36
111.8
Procedure End to Extubation (minutes)
No Complications
0
11.9
Complications
3
14.2
Procedure End to OR exit (minutes)
TIVA
0
18.9
Gas
0
19.1
Procedure End to OR exit (minutes)
No Complications
0
18.4
Complications
7
23.1
Fentanyl (mcg)
No Complications
0
124.3
Complications
0
138
Number of Stations Sampled
No Complications
1
2.69
Complications
1
3
Number of TBNA Needle Passes
No Complications
1
4.1
Complications
1
4.3

Max

P-value

Table 6. Multivariable linear regression of longer post-extubation OR
exit times on individual variables.

0.94

Outcomes and Covariates

p-value

Estimate

Outcome: Longer OR Exit Times
Weight (kg)
Fentanyl (mcg)
Ketamine

0.029
0.028
0.0018

0.052
0.013
9.09

a

91
86
0.31
163
189
0.00009
391
681
0.039
77
45
0.78
98
142
0.0016
98
142
0.64
500
750
0.084
7
7
0.52
10
9

Non-Categorical data are presented with Minimum (Min.), 1st
Quartile (Qu.), Median, Mean, 3rd Quartile (Qu.), and Maximum
(Max). Units are indicated where appropriate, Statistically signiﬁcant results are indicated in bold.
a
ManneWhitney U Test (Wilcoxon Rank Sum Test with continuity correction) was used to calculate p-values.

the incidence of respiratory complications, especially those not directly attributable to the invasiveness of the procedure itself. In this study, we
have retrospectively assessed 586 patients at a single
institution in order to determine what factors, if any,
inﬂuence the occurrence of perioperative respiratory complications under GA during EBUS-TBNA
including pre-existing patient characteristics and
anesthetic factors.
In the bivariate analysis, our ﬁndings show that
home oxygen use, pre-existing respiratory disease,
ASA score, and intra-operative albuterol use are all
associated with the occurrence of respiratory complications. The resultant patient characteristics are
not unexpected, as supplemental oxygen therapy is
a mainstay of treatment for seriously ill patients and

Statistically signiﬁcant results are indicated in bold.

those with advanced respiratory disease.29e31
However, no individual anesthetic factors assessed
were found to be associated with the occurrence of
respiratory complications. Of note, the changes in
respiratory physiology inherent to GA can
contribute to the development of respiratory complications in vulnerable patients with poor baseline
lung function, who are already at higher risk for a
procedural respiratory complication.32e34 Our results are notably different from Eapen et al., who
showed that transbronchial biopsy was the only risk
factor for complications during EBUS-TBNA, and
from Dhooria et al., who demonstrated a broad
range of complications but established no outlined
risk factors.10,12,35
Our study found no signiﬁcant association with
TIVA versus volatile inhalation anesthesia during
EBUS-TBNA and the incidence of respiratory complications. This result is inconclusive, especially
when considering the results of other studies. Lai
et al. demonstrated prolonged emergence and
extubation among patients who received inhalational anesthetics versus propofol-based TIVA.36 In
contrast, a systematic literature review by Gupta
et al. illustrated that emergence and early recovery
is faster among patients receiving desﬂurane or
sevoﬂurane compared to propofol.37 Furthermore,
propofol in combination with sevoﬂurane has been
demonstrated to lead to shorter awakening and
extubation times compared to pure volatile inhalational agents alone.38 Given our result, more
research must been done with regards to speciﬁc
anesthetic management and its effects on emergence and extubation during EBUS-TBNA to elucidate any association.
Interestingly, our study demonstrated that higher
fentanyl and ketamine doses are associated with
longer OR exit times. With regards to fentanyl, this

Table 5. Multivariable logistic regression of respiratory complications on individual variables.
Outcomes and Covariates

OR

CI (2.5%e97.5%)

p-value

Outcome: Any Respiratory Complication
Total Procedure Duration (minutes)
Albuterol Use Intraoperatively

0.016
1.83

1.008e1.024
1.007e3.226

<0.0001
0.041

Statistically signiﬁcant results are indicated in bold.

result is consistent with some established ﬁndings.
For example, patients undergoing coronary artery
bypass grafting surgery who received fentanyl
intraoperatively in place of shorter acting opiates
required a longer period of mechanical ventilation.39 However, other researchers observed that
short acting opiates are not more advantageous than
fentanyl as part of an intraoperative regimen.40,41
Lin et al. noted improved emergence when intraoperative fentanyl is used compared to tramadol
among neurosurgical patients.42 With regards to
ketamine, only two studies have assessed its efﬁcacy
and safety during EBUS-TBNA procedures. As an
anesthetic agent in EBUS-TBNA, ketamine has been
shown to be safe, efﬁcacious, and effective.19,22 In
this study, we demonstrate that ketamine is associated with prolonged time to OR exit in EBUS-TBNA
patients, providing new insight into its role in the
perioperative management in this cohort of patients.
However, given the small fraction of patients in this
study that received ketamine, this result requires
further future analysis.
Our study also reﬂects a particularly high
complication rate of 13.5%, especially when
compared to other published studies. Notably, one
of the largest EBUS-TBNA research efforts, the
AQuIRE study, is signiﬁcant for only 19 patient
complications among 1317 patients. These complications included sustained hypoxemia deﬁned as an
oxygen saturation <90% for >1 min, which is much
more liberal than our deﬁnition of SpO2 <90% for
>5 min. However, we do not view our higher
complication rate to be inaccurate. The AQuIRE
registry methods involved manual extraction of data
from procedural notes, versus our utilization of an
electronic medical recording system automatically
recording oxygen saturations every minute, to track
all hypoxemic events intraoperatively. Electronic
scanning has previously been shown to be signiﬁcantly more sensitive than voluntary reporting for
intraoperative hypoxemia, as demonstrated by
Sanborn et al. who showed that only 2 of their 54
prolonged desaturation events were reported
voluntarily.43 Thus, our higher complication rate
likely reﬂects better ascertainment of complications.
This study is limited in several regards. First, this is
a single site study with all EBUS-TBNA procedures
performed by a small group of physicians. While our
study had a relatively large sample size, further
research should be conducted to incorporate data
from a multi-center registry or data warehouse in
order to enhance its overall power and standardize
complication guidelines for greater consistency.
Second, as a retrospective study, we are dependent
on the observations and recordkeeping of others for
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appropriate assessment, and potentially subjected to
both selection and information bias. Third, our
complications represent only those that occurred in
the perioperative period as follow up after discharge
was not conducted. Fourth, selection of anesthetic
agents is not a random process and implicit to this is
an inherent bias. In this study, we do not address the
inherent selection biases on the part of the anesthesia
practitioners. In future studies, prospective
randomization would decrease this apparent bias.
Lastly, although patient characteristics are comparable between those with and without respiratory
complications, we cannot rule out the possibility that
practice evolution and trends or initiatives at our
institution may have confounded our results.
In summary, we conducted a novel retrospective
analysis of patients undergoing EBUS-TBNA to
investigate how patient characteristics and various
aspects of GA inﬂuence the occurrence of respiratory complications intraoperatively. Each case was
evaluated for respiratory complications that could
not be attributed to the invasiveness of the procedure itself. Here, we have identiﬁed variables that
inﬂuence the occurrence of respiratory complications and prolonged OR exit times. As such, we have
contributed to the dialogue regarding general
anesthetic techniques for EBUS-TBNA and identiﬁed particular patient elements that inﬂuence the
occurrence of respiratory complications. These
ﬁndings may be most helpful to individuals developing a program to risk-stratify patients through a
pre-procedural checklist or to provide an additional
layer of perioperative guidance to anesthesia
providers.
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